1. Section of Endocrinology, Department of Medicine (P.B.), Yale School of Medicine, New Haven, CT.
2. Section of General Internal Medicine, Department of Medicine (W.N.K), Yale School of Medicine, New Haven, CT.
3. Department of Neurology (K.N.S), Yale School of Medicine, New Haven, CT.
4. Boehringer Ingelheim Norway KS, Asker (A.P.O.).
5. Oslo Diabetes Research Center, Norway (A.P.O.).
6. Velocity Clinical Research at Medical City, Dallas, TX (J.R.).
7. Würzburg University Clinic, Germany (C.W.).
8. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, ON, Canada (B.Z.).
9. Boehringer Ingelheim Pharma GmbH & Co KG, Germany (M.M.).
10. Department of Internal Medicine, University Hospital; RWTH Aachen University, Germany (N.M.).
11. Section of Endocrinology, Department of Medicine (S.E.I), Yale School of Medicine, New Haven, CT.